<DOC>
	<DOC>NCT02083315</DOC>
	<brief_summary>This study is designed to compare TRV130 to placebo and morphine to learn about its effects on pain relief and side effects.</brief_summary>
	<brief_title>Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects</brief_title>
	<detailed_description>This study will explore the pharmacokinetics, pharmacodynamics (PD), safety and tolerability of TRV130.</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Informed consent Healthy adult males age 18 50 years, BMI 1932 kg/m2 Acceptable duration of cold pain test results at screening Clinically significant medical illness or physical exam findings Active dermatological conditions or skin trauma on the nondominant hand, or peripheral vascular disease Partial blindness, keratoconus, nystagmus or any other ophthalmic condition which could interfere with pupillometry Use of tobacco or nicotine within 6 months prior to screening History of recent (within 6 months) drug or alcohol abuse, as defined in DSMIVTR</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>acute pain, analgesia, respiratory drive, ventilator response to hypercapnia, pupillometry</keyword>
</DOC>